Midlife vs Late-Life Depressive Symptoms and Risk of Dementia Differential Effects for Alzheimer Disease and Vascular Dementia

被引:0
|
作者
Barnes, Deborah E. [1 ,2 ,4 ]
Yaffe, Kristine [1 ,2 ,3 ,4 ]
Byers, Amy L. [1 ,4 ]
McCormick, Mark [5 ]
Schaefer, Catherine [5 ]
Whitmer, Rachel A. [5 ]
机构
[1] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
[4] San Francisco VA Med Ctr, Mental Hlth Serv, San Francisco, CA USA
[5] Kaiser Div Res, Oakland, CA USA
基金
美国国家卫生研究院;
关键词
WHITE-MATTER HYPERINTENSITIES; MILD COGNITIVE IMPAIRMENT; TEMPORAL RELATIONSHIP; PREVALENCE; POPULATION; METAANALYSIS; ASSOCIATION; HYPOTHESIS; DECLINE;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Context: Depression and dementia are common in older adults and often co-occur, but it is unclear whether depression is an etiologic risk factor for dementia. Objective: To clarify the timing and nature of the association between depression and dementia. Design: We examined depressive symptoms assessed in midlife (1964-1973) and late life (1994-2000) and the risks of dementia, Alzheimer disease (AD), and vascular dementia (VaD) (2003-2009) in a retrospective cohort study. Depressive symptoms were categorized as none, midlife only, late life only, or both. Cox proportional hazards models (age as timescale) adjusted for demographics and medical comorbidities were used to examine depressive symptom category and risk of dementia, AD, or VaD. Setting: Kaiser Permanente Medical Care Program of Northern California. Participants: Thirteen thousand five hundred thirty-five long-term Kaiser Permanente members. Main Outcome Measure: Any medical record diagnosis of dementia or neurology clinic diagnosis of AD or VaD. Results: Subjects had a mean (SD) age of 81.1 (4.5) years in 2003, 57.9% were women, and 24.2% were non-white. Depressive symptoms were present in 14.1% of subjects in midlife only, 9.2% in late life only, and 4.2% in both. During 6 years of follow-up, 22.5% were diagnosed with dementia (5.5% with AD and 2.3% with VaD). The adjusted hazard of dementia was increased by approximately 20% for midlife depressive symptoms only (hazard ratio, 1.19 [95% CI, 1.07-1.32]), 70% for latelife symptoms only (1.72 [1.54-1.92]), and 80% for both (1.77 [1.52-2.06]). When we examined AD and VaD separately, subjects with late-life depressive symptoms only had a 2-fold increase in AD risk (hazard ratio, 2.06 [95% CI, 1.67-2.55]), whereas subjects with midlife and latelife symptoms had more than a 3-fold increase in VaD risk (3.51 [2.44-5.05]). Conclusions: Depressive symptoms in midlife or in late life are associated with an increased risk of developing dementia. Depression that begins in late life may be part of the AD prodrome, while recurrent depression may be etiologically associated with increased risk of VaD.
引用
收藏
页码:493 / 498
页数:6
相关论文
共 50 条
  • [41] Vascular Risk Factors and Neurodegeneration in Ageing Related Dementias: Alzheimer's Disease and Vascular Dementia
    Akinyemi, Rufus O.
    Mukaetova-Ladinska, Elizabeta B.
    Attems, Johannes
    Ihara, Masafumi
    Kalaria, Raj N.
    CURRENT ALZHEIMER RESEARCH, 2013, 10 (06) : 642 - 653
  • [42] Gray matter volume in women with the BRCA mutation with and without ovarian removal: evidence for increased risk of late-life Alzheimer's disease or dementia
    Witt, Suzanne T.
    Brown, Alana
    Gravelsins, Laura
    Engstrom, Maria
    Classon, Elisabet
    Lykke, Nina
    Avall-Lundqvist, Elisabeth
    Theordorsson, Elvar
    Ernerudh, Jan
    Kjolhede, Preben
    Einstein, Gillian
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2024, 31 (07): : 608 - 616
  • [43] Late-Life Depression as a Risk Factor for Mild Cognitive Impairment or Alzheimer's Disease in 30 US Alzheimer's Disease Centers
    Steenland, Kyle
    Karnes, Conny
    Seals, Ryan
    Carnevale, Claudine
    Hermida, Adriana
    Levey, Allan
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 31 (02) : 265 - 275
  • [44] Systolic blood pressure variability in late-life predicts cognitive trajectory and risk of Alzheimer's disease
    Li, Xiao-Lu
    Wang, Ruo-Tong
    Tan, Chen-Chen
    Tan, Lan
    Xu, Wei
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [45] Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant Alzheimer's Disease
    Acosta-Baena, Natalia
    Lopera-Gomez, Carlos M.
    Jaramillo-Elorza, Mario C.
    Velilla-Jimenez, Lina
    Andres Villegas-Lanau, Carlos
    Sepulveda-Falla, Diego
    Arcos-Burgos, Mauricio
    Lopera, Francisco
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 92 (03) : 911 - 923
  • [46] Polysocial and Polygenic Risk Scores and All-Cause Dementia, Alzheimer's Disease, and Vascular Dementia
    Li, Yueying
    Zeng, Zhiqing
    Zhuang, Zhenhuang
    Zhao, Yimin
    Zhang, Linjing
    Wang, Wenxiu
    Song, Zimin
    Dong, Xue
    Xiao, Wendi
    Huang, Ninghao
    Jia, Jinzhu
    Liu, Zhonghua
    Qi, Lu
    Huang, Tao
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2024, 79 (03):
  • [47] Age-Related Hearing Loss, Late-Life Depression, and Risk for Incident Dementia in Older Adults
    Brewster, Katharine K.
    Hu, Mei-Chen
    Zilcha-Mano, Sigal
    Stein, Alexandra
    Brown, Patrick J.
    Wall, Melanie M.
    Roose, Steven P.
    Golub, Justin S.
    Rutherford, Bret R.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2021, 76 (05): : 827 - 834
  • [48] Mid- and Late-Life Physical Activity and Neuropsychiatric Symptoms in Dementia-Free Older Adults: Mayo Clinic Study of Aging
    Krell-Roesch, Janina
    Syrjanen, Jeremy A.
    Bezold, Jelena
    Trautwein, Sandra
    Barisch-Fritz, Bettina
    Kremers, Walter K.
    Fields, Julie A.
    Scharf, Eugene L.
    Knopman, David S.
    Stokin, Gorazd B.
    Petersen, Ronald C.
    Jekauc, Darko
    Woll, Alexander
    Vassilaki, Maria
    Geda, Yonas E.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2023, 35 (02) : 133 - 140
  • [49] Blood Pressure, Antihypertensive Use, and Late-Life Alzheimer and Non-Alzheimer Dementia An Individual Participant Data Meta-Analysis
    Lennon, Matthew J.
    Lipnicki, Darren M.
    Lam, Ben Chun Pan
    Crawford, John D.
    Schutte, Aletta E.
    Peters, Ruth
    Rydberg-Sterner, Therese
    Najar, Jenna
    Skoog, Ingmar
    Riedel-Heller, Steffi G.
    Rohr, Susanne
    Pabst, Alexander
    Lobo, Antonio
    De-la-Camara, Concepcion
    Lobo, Elena
    Lipton, Richard B.
    Katz, Mindy J.
    Derby, Carol A.
    Kim, Ki Woong
    Han, Ji Won
    Oh, Dae Jong
    Rolandi, Elena
    Davin, Annalisa
    Rossi, Michele
    Scarmeas, Nikolaos
    Yannakoulia, Mary
    Dardiotis, Themis
    Hendrie, Hugh C.
    Gao, Sujuan
    Carriere, Isabelle
    Ritchie, Karen
    Anstey, Kaarin J.
    Cherbuin, Nicolas
    Xiao, Shifu
    Yue, Ling
    Li, Wei
    Guerchet, Maelenn
    Preux, Pierre-Marie
    Aboyans, Victor
    Haan, Mary N.
    Aiello, Allison
    Scazufca, Marcia
    Sachdev, Perminder S.
    NEUROLOGY, 2024, 103 (05)
  • [50] Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index
    Vos, Stephanie J. B.
    van Boxtel, Martin P. J.
    Schiepers, Olga J. G.
    Deckers, Kay
    de Vugt, Marjolein
    Carriere, Isabelle
    Dartigues, Jean-Francois
    Peres, Karine
    Artero, Sylvaine
    Ritchie, Karen
    Galluzzo, Lucia
    Scafato, Emanuele
    Frison, Giovanni B.
    Huisman, Martijn
    Comijs, Hannie C.
    Sacuiu, Simona F.
    Skoog, Ingmar
    Irving, Kate
    O'Donnell, Catherine A.
    Verhey, Frans R. J.
    Visser, Pieter Jelle
    Kohler, Sebastian
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 58 (02) : 537 - 547